Toward Better Vaccines

A QUANTUM OF SCIENCE

Making vaccines both optimally effective and optimally safe may be an easier task in the near future

Vaccines have an overwhelming track record when it comes to preventing illness, and thanks in part to conservative rules put in place by the federal agencies regulating them vaccines have also been extremely safe. Still, there’s an unadvertised trade-off in that compromise: vaccines would be even more effective than they are today if they could be made with heat-inactivated pathogens rather than highly purified microbial proteins generated in non-toxic bacteria, but that elevates the risk of possible immune reactions and side effects in those who take the vaccine.

To help improve the effectiveness of vaccines even when not using the heat-inactivated pathogens, scientists have long used compounds known as adjuvants to "boost" the body’s immune response. In essence, adjuvants are sensitizers that tell the body to be ready for an invader; when given as part of a vaccination, adjuvants significantly increase the vaccine’s protective effects both in duration and potency. But the only adjuvant ever approved for use in humans, aluminum hydroxide (or alum), is far from the most effective compound for the job. To date the FDA has been extremely reluctant to approve other, more powerful adjuvants for use with vaccines because of concerns about toxicity and possible side-effects.

Now scientists at Oregon State University have developed an adjuvant based on lecithin, a common food product, that shows six-fold greater immune response when administered as part of a vaccine as compared to alum-based treatments. Lecithin is part of a category of food products termed "generally recognized as safe" by the FDA, meaning that it is non-toxic in almost any dosage. This could mean a fast track to approval and, very possibly, vaccines that would be more effective, for longer periods of time, with smaller doses and fewer injections.

For more information:

New adjuvant could hold future of vaccine development

Adjuvant (Wikipedia article)

Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles (Sloat et al)


© AQOS / P. Smalley (2009)
Reproduction with attribution is appreciation